Applying High-Resolution Variant Classification to Cardiac Arrhythmogenic Gene Testing in a Demographically Diverse Cohort of Sudden Unexplained Deaths.

Main|Search|PHGKB




Last Posted: Dec 21, 2017

---

• Applying High-Resolution Variant Classification to Cardiac Arrhythmogenic Gene Testing in a Demographically Diverse Cohort of Sudden Unexplained Deaths.  
  Lin Ying et al. Circulation. Cardiovascular genetics 2017 Dec 10(6)
• Next-generation sequencing in clinical practice: from the patients' preferences to the informed consent process.  
  Pélissier A et al. Public health 2016 138157-9
• "Not pathogenic until proven otherwise”: perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project  
  E Onrmondroyd et al, genetics in Medicine, Oct 26, 2017
• The who, what, and why of research participants’ intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study 
  C Rini et al, Genetics in Medicine, Oct 26, 2017
• High participation rate among 25 721 patients with broad age range in a hospital-based research project involving whole-genome sequencing - the Lausanne Institutional Biobank.  
  Bochud Murielle et al. Swiss medical weekly 2017 Oct 147w14528
• Navigating social and ethical challenges of biobanking for human microbiome research.  
  Chuong Kim H et al. BMC medical ethics 2017 Jan 18(1) 1
• Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study.  
  Heong Valerie et al. International journal of cancer 2017 Oct
• Exploring the potential duty of care in clinical genomics under UK law.  
  Mitchell Colin et al. Medical law international 2017 Sep 17(3) 158-182
• CNVs affecting cancer predisposing genes (CPGs) detected as incidental findings in routine germline diagnostic chromosomal microarray (CMA) testing.  
  Innes Josie et al. Journal of medical genetics 2017 Sep
• Genomic sequencing identifies secondary findings in a cohort of parent study participants  
  ML Thompson et al, BioRxIV, September 1, 2017
• Stakeholders in psychiatry and their attitudes toward receiving pertinent and incident findings in genomic research.  
  Sundby Anna et al. American journal of medical genetics. Part A 2017 Aug
• Population-based biobank participants' preferences for receiving genetic test results.  
  Yamamoto Kayono et al. Journal of human genetics 2017 Aug
• Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs).  
  Ploug Thomas et al. PloS one 2017 12(7) e0179935
• Informed consent for next-generation nucleotide sequencing studies: Aiding communication between participants and investigators.  
  Kost Rhonda G et al. Journal of clinical and translational science 2017 Apr 1(2) 115-120
• Ethical considerations in genomic testing for hematologic disorders.  
  Marron Jonathan M et al. Blood 2017 Jun
• Personal utility in genomic testing: is there such a thing?  
  Bunnik Eline M et al. Journal of medical ethics 2015 Apr (4) 322-6

more